These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25187078)

  • 1. Advances in clinical applications of tissue proteomics: opportunities and challenges.
    Dogan A
    Expert Rev Proteomics; 2014 Oct; 11(5):531-3. PubMed ID: 25187078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.
    Manes NP; Nita-Lazar A
    J Proteomics; 2018 Oct; 189():75-90. PubMed ID: 29452276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in mass spectrometry proteomics for biomedical research.
    Li X; Wang W; Chen J
    Sci China Life Sci; 2017 Oct; 60(10):1093-1113. PubMed ID: 29039124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry-based proteomics in biomedical research: emerging technologies and future strategies.
    Walsh GM; Rogalski JC; Klockenbusch C; Kast J
    Expert Rev Mol Med; 2010 Sep; 12():e30. PubMed ID: 20860882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shotgun-proteomics-based clinical testing for diagnosis and classification of amyloidosis.
    Theis JD; Dasari S; Vrana JA; Kurtin PJ; Dogan A
    J Mass Spectrom; 2013 Oct; 48(10):1067-77. PubMed ID: 24130009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics approaches in the quest of kidney disease biomarkers.
    Frantzi M; Bitsika V; Charonis A; Vlahou A
    Prilozi; 2011; 32(2):33-51. PubMed ID: 22286613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in tissue proteome associated with ATTR amyloidosis: insights into pathogenesis.
    Brambilla F; Lavatelli F; Valentini V; Di Silvestre D; Obici L; Mauri P; Merlini G
    Amyloid; 2012 Jun; 19 Suppl 1():11-3. PubMed ID: 22551153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry-based membrane proteomics in cancer biomarker discovery.
    Mermelekas G; Zoidakis J
    Expert Rev Mol Diagn; 2014 Jun; 14(5):549-63. PubMed ID: 24820261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities for nanotechnology-based innovation in tissue proteomics.
    Geho DH; Lahar N; Ferrari M; Petricoin EF; Liotta LA
    Biomed Microdevices; 2004 Sep; 6(3):231-9. PubMed ID: 15377833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular make-up of a tumour: proteomics in cancer research.
    Kolch W; Mischak H; Pitt AR
    Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in proteomic profiling of human blood: clinical scope.
    Archakov A; Lisitsa A; Ponomarenko E; Zgoda V
    Expert Rev Proteomics; 2015 Apr; 12(2):111-3. PubMed ID: 25711363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of quantification techniques in proteomics for biomedical research.
    Rodríguez-Suárez E; Whetton AD
    Mass Spectrom Rev; 2013; 32(1):1-26. PubMed ID: 22847841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplexed and data-independent tandem mass spectrometry for global proteome profiling.
    Chapman JD; Goodlett DR; Masselon CD
    Mass Spectrom Rev; 2014; 33(6):452-70. PubMed ID: 24281846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical proteomics: current status, challenges, and future perspectives.
    Chiou SH; Wu CY
    Kaohsiung J Med Sci; 2011 Jan; 27(1):1-14. PubMed ID: 21329886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.
    Boja ES; Fehniger TE; Baker MS; Marko-Varga G; Rodriguez H
    J Proteome Res; 2014 Dec; 13(12):5325-32. PubMed ID: 25171765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer proteomics.
    Tan HT; Lee YH; Chung MC
    Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloidosis: Insights from Proteomics.
    Dogan A
    Annu Rev Pathol; 2017 Jan; 12():277-304. PubMed ID: 27959636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four areas of engagement requiring strengthening in modern proteomics today.
    Fehniger TE; Boja ES; Rodriguez H; Baker MS; Marko-Varga G
    J Proteome Res; 2014 Dec; 13(12):5310-8. PubMed ID: 25405748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry: uncovering the cancer proteome for diagnostics.
    van der Merwe DE; Oikonomopoulou K; Marshall J; Diamandis EP
    Adv Cancer Res; 2007; 96():23-50. PubMed ID: 17161675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.